Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Conduit Pharmaceuticals Inc. - Common Stock (NQ: CDT ) 0.1124 +0.0109 (+10.74%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Conduit Pharmaceuticals Inc. - Common Stock Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference August 28, 2024 From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders August 12, 2024 From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments August 08, 2024 From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases July 16, 2024 Composition of matter patent approval underscores the Company’s solid-form technology to maximize future value and ability to strengthen and broaden its intellectual property portfolio From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals to Join Russell 3000® Index June 13, 2024 From Conduit Pharmaceuticals Via GlobeNewswire A Presidio Property Trust Major Investment To Be Part of Russell 2000® May 29, 2024 From Presidio Property Trust, Inc. Via GlobeNewswire Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer March 19, 2024 From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub March 11, 2024 From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference January 31, 2024 From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference November 02, 2023 From Conduit Pharmaceuticals Via GlobeNewswire Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656 October 11, 2023 Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed Phase I trials From Conduit Pharmaceuticals Via GlobeNewswire Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW) October 06, 2023 From Presidio Property Trust, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.